Cold Spring Harbor Laboratory-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cold Spring Harbor Laboratory - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013990
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution’s research services include graduate research, research training, clinical research, quantitative biology research, postdoctoral research, disease research, and scientific research services. Its educational services comprise undergraduate research programs, postgraduate programs, Ph.D. programs, education resources programs, DNA learning centres services, and primary and secondary educational services. CSHL conducts research in the fields of cancer, plant biology, neuroscience, bioinformatics, quantitative biology, genomics, and biological sciences. The institution provides diagnosis and treatment of cancer, neurological disorders and other diseases. It offers its services to scientists in universities, hospitals, and biotech and pharmaceutical sectors. CSHL is headquartered in Cold Spring Harbor, New York, the US.

Cold Spring Harbor Laboratory – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cold Spring Harbor Labs Enters into Co-Development Agreement with GlaxoSmithKline 10
Ohr Pharma Forms Joint Venture With Cold Spring Harbor Lab 11
Cold Spring Harbor Labs Enters Into Research Agreement With Pfizer For New Cancer Therapies 12
Licensing Agreements 13
uniQure Enters into Licensing Agreement with Cold Spring Harbor Laboratory 13
Hairpin Technologies Enters into Licensing Agreement with Cold Spring Harbor Labs 14
Cold Spring Harbor Laboratory – Key Competitors 15
Cold Spring Harbor Laboratory – Key Employees 16
Cold Spring Harbor Laboratory – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Government and Public Interest 18
Nov 16, 2017: 12th Double Helix Medal dinner raises $4.5 million for research & education at Cold Spring Harbor Laboratory 18
Oct 05, 2017: First cell-type census of mouse brains: surprises about structure, male-female differences 19
Dec 08, 2016: Researchers identify potentially druggable mutant p53 proteins that promote cancer growth 20
Nov 08, 2016: Pancreas and Colon Tumors Reprogram the Liver, causing wasting and short-circuiting Body’s Immune Response 21
Jul 28, 2016: Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants 22
Jan 29, 2016: Christina Renna Foundation Raises $35,000 for pediatric cancer research at CSHL 24
Other Significant Developments 25
Jan 11, 2017: CSHL joins NCI-designated cancer centers in endorsing updated HPV vaccination recommendations 25
Jan 27, 2016: CSHL Joins nation’s Cancer Centers in Endorsement of HPV vaccination for Cancer Prevention 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cold Spring Harbor Laboratory, Deals By Therapy Area, 2011 to YTD 2017 8
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cold Spring Harbor Labs Enters into Co-Development Agreement with GlaxoSmithKline 10
Ohr Pharma Forms Joint Venture With Cold Spring Harbor Lab 11
Cold Spring Harbor Labs Enters Into Research Agreement With Pfizer For New Cancer Therapies 12
uniQure Enters into Licensing Agreement with Cold Spring Harbor Laboratory 13
Hairpin Technologies Enters into Licensing Agreement with Cold Spring Harbor Labs 14
Cold Spring Harbor Laboratory, Key Competitors 15
Cold Spring Harbor Laboratory, Key Employees 16
Cold Spring Harbor Laboratory, Joint Venture 17

★海外企業調査レポート[Cold Spring Harbor Laboratory-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MedMira Inc (MIR):企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Tetra Discovery Partners LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Tetra Discovery Partners LLC (Tetra Discovery) is a drug development company that researches and develops pharmaceutical drugs based on phosphodiesterase (PDE) sub-type inhibitors for neuroscience and non-neuroscience disorders. The company uses structure-guided drug design chemistry approac …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Vanda Pharmaceuticals Inc (VNDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • Symphogen AS-製薬・医療分野:企業M&A・提携分析
    Summary Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb) mixture therapeutics to enhance the lives of patients with cancer and ot …
  • Callaway Golf Company (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Company (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Chugai Pharmaceutical Co Ltd (4519):製薬・医療:M&Aディール及び事業提携情報
    Summary Chugai Pharmaceutical Co Ltd (Chugai) is a subsidiary of Hoffmann-La Roche Ltd, which focuses on the research, development, manufacture, commercialization, import and export of the biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone an …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • City Lodge Hotels Limited:戦略・SWOT・企業財務分析
    City Lodge Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary City Lodge Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Larsen & Toubro Limited:企業の戦略・SWOT・財務情報
    Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report Summary Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Horizon Discovery Group Plc:企業のM&A・事業提携・投資動向
    Horizon Discovery Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Horizon Discovery Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns and operates outpatient surgical centres, hospitals, medical network, and cent …
  • Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the o …
  • CMA CGM SA:戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AstraZeneca KK-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆